Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

Market Cap	2.38B -30.9%
Revenue (ttm)	832.86M -1.3%
Net Income	44.88M -11.5%
EPS	0.24 -15.6%
Shares Out	187.44M
PE Ratio	52.35
Forward PE	n/a
Dividend	0.10 (0.78%)
Ex-Dividend Date	Jul 1, 2026

Volume	4,352,100
Open	12.97
Previous Close	13.08
Day's Range	12.70 - 13.06
52-Week Range	9.94 - 22.00
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:603079

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the developing, producing, and selling of food and feed additives in China and internationally. The company offers vitamins, such as biotin and folic acid; biopreservatives and functional ingredients, including nisin, natamycin, polylysine, and sucrose fermentation products; and intermediate APIs. It serves pharmaceutical, nutritional, food, and animal feed industries. The company was incorporated in 1999 and is headquartered in Tiantai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 1,083
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603079

Financial Performance

In 2025, SHA:603079's revenue was 844.54 million, an increase of 2.07% compared to the previous year's 827.40 million. Earnings were 62.16 million, an increase of 111.24%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 10, 2026

Data Sources Report a data error